Covidien will acquire a company that markets a swallowed capsule used in medical imaging for $860 million, the hospital equipment manufacturer said Sunday.
Covidien has finished spinning off its pharmaceuticals division, the medical products maker said.
Medical products manufacturer Covidien's pharmaceutical division is expanding an initiative to collect unused and unwanted medications.
Watson Pharmaceuticals and Mallinckrodt have reached a settlement concerning a painkiller for which the former had sought Food and Drug Administration approval.
The Food and Drug Administration has approved an opioid painkiller made by Covidien's generic drug division, the medical supply company said.